Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study
NCT07739485
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Triple -Negative Breast Cancer
Interventions
DRUG:
Epirubicin and cyclophosphamide followed by paclitaxel oral solution
Sponsor
Liu Shu